Roswell Park Team Identifies Possible Cause of Resistance to Prostate Cancer Treatment
September 06, 2018
September 06, 2018
BUFFALO, New York, Sept. 6 -- The Roswell Park Cancer Institute issued the following news release:
A collaborative research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor (AR) expression in prostate cancer cells, identifying a new therapeutic target for one of the deadliest forms of cancer among men. Results of this research, which was led by scientists at Roswell Park Comprehensive Cancer Center, we . . .
A collaborative research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor (AR) expression in prostate cancer cells, identifying a new therapeutic target for one of the deadliest forms of cancer among men. Results of this research, which was led by scientists at Roswell Park Comprehensive Cancer Center, we . . .